| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 46.361 | 43.726 | 45.575 | 40.797 | 47.548 | 40.448 | 44.217 | 46.624 | 51.352 | 60.611 |
| Total Income - EUR | 46.361 | 44.278 | 45.955 | 40.884 | 47.557 | 40.639 | 44.218 | 46.626 | 51.355 | 60.615 |
| Total Expenses - EUR | 13.250 | 13.977 | 10.787 | 11.125 | 17.243 | 15.452 | 18.680 | 19.180 | 21.816 | 24.952 |
| Gross Profit/Loss - EUR | 33.111 | 30.301 | 35.167 | 29.759 | 30.314 | 25.187 | 25.538 | 27.446 | 29.539 | 35.663 |
| Net Profit/Loss - EUR | 31.720 | 28.972 | 33.794 | 28.533 | 29.838 | 24.808 | 25.096 | 26.979 | 29.025 | 33.844 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Viamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 876 | 543 | 331 | 205 | 1.020 | 810 | 686 | 583 | 475 | 1.022 |
| Current Assets | 51.207 | 47.667 | 35.708 | 33.130 | 62.938 | 24.695 | 38.957 | 46.104 | 31.325 | 40.704 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 8.131 | 8.769 | 7.492 | 6.928 | 26.679 | 2.940 | 4.394 | 25.517 | 23.947 | 32.100 |
| Cash | 43.076 | 38.898 | 28.216 | 26.202 | 36.259 | 21.755 | 34.563 | 20.587 | 7.378 | 8.604 |
| Shareholders Funds | 50.033 | 44.601 | 33.847 | 28.584 | 50.962 | 24.857 | 25.145 | 27.028 | 29.074 | 33.892 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.206 | 3.625 | 2.204 | 4.761 | 13.006 | 683 | 14.512 | 19.666 | 2.883 | 7.994 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Viamed Srl